FAMI vs PRLB vs AVO vs SSYS

For growth investors, Mission Produce, Inc.

(AVO) is the stronger pick with 12. 7% revenue growth year-over-year, versus -41. 9% for Farmmi, Inc. (FAMI). Mission Produce, Inc. (AVO) offers the better valuation at 25. 1x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate Mission Produce, Inc. (AVO) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Mission Produce, Inc.

(AVO) is the cheapest at 25. 1x versus Proto Labs, Inc. at 77. 3x. On forward P/E, Mission Produce, Inc. is actually cheaper at 20. 2x.

Over the past 5 years, Proto Labs, Inc.

(PRLB) delivered a total return of -32. 9%, compared to -99. 9% for Farmmi, Inc. (FAMI). Over 10 years, the gap is even starker: PRLB returned +13. 7% versus FAMI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Mission Produce, Inc.

(AVO) is the lower-risk stock at 0. 32β versus Proto Labs, Inc. 's 1. 84β — meaning PRLB is approximately 482% more volatile than AVO relative to the S&P 500. On balance sheet safety, Proto Labs, Inc. (PRLB) carries a lower debt/equity ratio of 1% versus 32% for Mission Produce, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Mission Produce, Inc.

(AVO) is pulling ahead at 12. 7% versus -41. 9% for Farmmi, Inc. (FAMI). On earnings-per-share growth, the picture is similar: Proto Labs, Inc. grew EPS 33. 3% year-over-year, compared to -118. 3% for Farmmi, Inc.. Over a 3-year CAGR, FAMI leads at 17. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Proto Labs, Inc.

(PRLB) is the more profitable company, earning 4. 0% net margin versus -18. 9% for Stratasys Ltd. — meaning it keeps 4. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVO leads at 5. 1% versus -10. 7% for SSYS. At the gross margin level — before operating expenses — SSYS leads at 47. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Mission Produce, Inc.

(AVO) trades at 20. 2x forward P/E versus 69. 8x for Stratasys Ltd. — 49. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SSYS: 64. 6% to $13. 50.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Mission Produce, Inc.

(AVO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 32)). Stratasys Ltd. (SSYS) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVO: -3. 6%, SSYS: -60. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FAMI (Consumer Defensive) and PRLB (Industrials) and AVO (Consumer Defensive) and SSYS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.